Search Results

There are 11541 results for: content related to: Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment

  1. You have free access to this content
    Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment—A position paper of the The Obesity Society and the American Society of Hypertension


    Volume 21, Issue 1, January 2013, Pages: 8–24, Lewis Landsberg, Louis J. Aronne, Lawrence J. Beilin, Valerie Burke, Leon I. Igel, Donald Lloyd-Jones and James Sowers

    Version of Record online : 20 DEC 2012, DOI: 10.1002/oby.20181

  2. Developmental origins of obesity-related hypertension

    Clinical and Experimental Pharmacology and Physiology

    Volume 39, Issue 9, September 2012, Pages: 799–806, Sarah L Henry, Benjamin Barzel, Ryan J Wood-Bradley, Sandra L Burke, Geoffrey A Head and James A Armitage

    Version of Record online : 28 AUG 2012, DOI: 10.1111/j.1440-1681.2011.05579.x

  3. Mechanisms linking obesity to hypertension

    Obesity Reviews

    Volume 13, Issue 1, January 2012, Pages: 17–26, J. A. N. Dorresteijn, F. L. J. Visseren and W. Spiering

    Version of Record online : 10 AUG 2011, DOI: 10.1111/j.1467-789X.2011.00914.x

  4. You have free access to this content
    Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies


    Volume 23, Issue S2, July 2015, Pages: S1–S26, Caroline M. Apovian, W. Timothy Garvey and Donna H. Ryan

    Version of Record online : 7 JUL 2015, DOI: 10.1002/oby.21140

  5. Long-term effects of weight-reducing drugs in people with hypertension

    Intervention Review

    The Cochrane Library

    Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Andrea Berghold, Nicole Posch, Jutta Meschik and Thomas Semlitsch

    Published Online : 2 MAR 2016, DOI: 10.1002/14651858.CD007654.pub4

  6. Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1228–1238, Dr Carol Addy, Ms Patricia Jumes, Ms Kimberly Rosko, Dr Susie Li, Dr Hankun Li, Dr Andrea Maes, Dr Amy O. Johnson-Levonas, Dr Jeffrey Chodakewitz, Dr S. Aubrey Stoch and Dr John A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009341651

  7. Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 10, October 2010, Pages: 876–882, J. G. Kang, C.-Y. Park, J. H. Kang, Y.-W. Park and S. W. Park

    Version of Record online : 26 MAY 2010, DOI: 10.1111/j.1463-1326.2010.01242.x

  8. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan


    Volume 59, Issue 5, April 2006, Pages: 277–289, A.K. Halladay, G.C. Wagner, A. Sekowski, R.B. Rothman, M.H. Baumann and H. Fisher

    Version of Record online : 13 JAN 2006, DOI: 10.1002/syn.20239

  9. You have free access to this content
    Renal sympathoinhibitory and regional vasodilator responses to cholecystokinin are altered in obesity-related hypertension

    Experimental Physiology

    Volume 98, Issue 3, March 2013, Pages: 655–664, Jackie M. Y. How, Talia J. Pumpa and Daniela M. Sartor

    Version of Record online : 8 JAN 2013, DOI: 10.1113/expphysiol.2012.070151

  10. You have free access to this content
    Do we need anti-obesity drugs?

    Diabetes/Metabolism Research and Reviews

    Volume 28, Issue s2, December 2012, Pages: 8–20, Vojtěch Hainer and Irena Aldhoon Hainerová

    Version of Record online : 28 DEC 2012, DOI: 10.1002/dmrr.2349

  11. You have free access to this content
    Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity


    Volume 19, Issue 12, December 2011, Pages: 2351–2360, Ed J. Hendricks, Frank L. Greenway, Eric C. Westman and Alok K. Gupta

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2011.94

  12. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine


    Volume 38, Issue 4, 15 December 2000, Pages: 471–476, Brian T. Callahan, Jie Yuan and George A. Ricaurte

    Version of Record online : 18 OCT 2000, DOI: 10.1002/1098-2396(20001215)38:4<471::AID-SYN12>3.0.CO;2-6

  13. You have free access to this content
    Pharmaceutical Cost Savings of Treating Obesity with Weight Loss Medications

    Obesity Research

    Volume 7, Issue 6, November 1999, Pages: 523–531, Frank L. Greenway, Donna H. Ryan, George A. Bray, Jennifer C. Rood, Elizabeth W. Tucker and Steven R. Smith

    Version of Record online : 6 SEP 2012, DOI: 10.1002/j.1550-8528.1999.tb00709.x

  14. You have full text access to this OnlineOpen article
    Current and emerging medications for overweight or obesity in people with comorbidities

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 11, November 2015, Pages: 1021–1032, K. Fujioka

    Version of Record online : 8 JUL 2015, DOI: 10.1111/dom.12502

  15. You have free access to this content
    Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms

    The Journal of Physiology

    Volume 592, Issue 7, 1 April 2014, Pages: 1705–1720, Jackie M. Y. How, Suhail A. Wardak, Shaik I. Ameer, Rachel A. Davey and Daniela M. Sartor

    Version of Record online : 12 MAR 2014, DOI: 10.1113/jphysiol.2013.269670

  16. Lower dosages of phentermine-fenfluramine given in the afternoon: Five cases with significant weight loss

    International Journal of Eating Disorders

    Volume 25, Issue 4, May 1999, Pages: 469–474, Debra A. Katz, Michael J. Maloney, Jerry C. Sutkamp and Brian J. McConville

    Version of Record online : 4 MAY 1999, DOI: 10.1002/(SICI)1098-108X(199905)25:4<469::AID-EAT13>3.0.CO;2-H

  17. Antiobesity Pharmacotherapy: New Drugs and Emerging Targets

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 53–66, GW Kim, JE Lin, ES Blomain and SA Waldman

    Version of Record online : 19 DEC 2013, DOI: 10.1038/clpt.2013.204

  18. You have free access to this content
    How Physician Obesity Specialists Use Drugs to Treat Obesity


    Volume 17, Issue 9, September 2009, Pages: 1730–1735, Ed J. Hendricks, Richard B. Rothman and Frank L. Greenway

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2009.69

  19. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications


    Volume 36, Issue 2, May 2000, Pages: 102–113, M.H. Baumann, M.A. Ayestas, C.M. Dersch, A. Brockington, K.C. Rice and R.B. Rothman

    Version of Record online : 31 MAR 2000, DOI: 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#

  20. You have free access to this content
    Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial


    Volume 18, Issue 9, September 2010, Pages: 1739–1746, Louis J. Aronne, Amy E. Halseth, Colleen M. Burns, Stephan Miller and Larry Z. Shen

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2009.478